Thromboprophylaxis by Low Molecular Heparin During the Post-partum Period

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to determine the current level of adequacy of the thromboprophylaxis prescriptions with the specific institutional protocol during the post-partum period. The institutional protocol is based on national and international guidelines.

Detailed Description
-----------------
Venous thromboembolism (VTE) became the 4th cause of maternal mortality and the 2nd direct cause of maternal mortality in France. The re are only few randomized studies on the thromboprophylaxis during the post-partum period. This expose some discrepancy between French guidelines, French Society of Anesthesia & Intensive Care Medecine (SFAR) and National College of French Gynecologists and Obstetricians (CNGOF ). The duration and adequate dose of low molecular heparin prescriptions are unclear. The level of adequacy of thromboprophylaxis prescriptions at Centre Hospitalier Sud Francilien with the SFAR recommendations appears to be less than 50 % in a preliminary unpublished study. Since this assessment, institutional protocol synthesizing thromboprophylaxis guidelines during the post-partum was exposed and validated among medical staff (both anaesthesiologists ang obstetricians).

Official Title
-----------------
Adherence Between Thromboprophylaxis Prescriptions and Guidelines During the Post-partum Period After the Institution of a Local Protocol

Conditions
-----------------
Thromboembolic Disease

Intervention / Treatment
-----------------
* Other: medical data collection


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: >18 ages Who had given birth at Centre Hospitalier Sud Francilien Hospitalized during the puerperium at Centre Hospitalier Sud Francilien Being informed of the clinical trial and had offered any opposition for data collection Exclusion Criteria: Curative treatment of thrombosis by Low molecular-weight or unfractioned heparin during pregnancy or post-partum period Curative anticoagulant therapy for any cause

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
Female

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: medical data collection|collection of medical data from patients' medical records|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Level of adequacy of the thromboprophylaxis prescriptions with the specific institutional protocol during the post-partum period | Level of adequacy of the thromboprophylaxis prescriptions with the specific institutional protocol during the post-partum period | at one year | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Level of adequacy of the thromboprophylaxis prescriptions with the specific institutional protocol after spontaneous or induced vaginal delivery. | Level of adequacy of the thromboprophylaxis prescriptions with the specific institutional protocol after spontaneous or induced vaginal delivery. | at one year | 
| Level of adequacy of the thromboprophylaxis prescriptions with the specific institutional protocol after a elective or urgent caesar section | Level of adequacy of the thromboprophylaxis prescriptions with the specific institutional protocol after a elective or urgent caesar section | at one year | 
| causes of non-compliant prescriptions with the institutional protocol. | Identify the causes of non-compliant prescriptions with the institutional protocol. | at one year | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Thromboembolic disease, Thromboprophylaxis, Post-partum period, Pregnancy, low molecular heparin